A Single Center Experience of Super-Responders Among Severe Asthma Patients Receiving Treatment with Mepolizumab

OBJECTIVE: Anecdotal reports among clinicians treating severe asthma patients with novel add-on treatments such as mepolizumab suggest that a fraction of these patients may experience a much more dramatic benefit from these agents than reported in large, randomized controlled studies. Although these...

Descripción completa

Detalles Bibliográficos
Autores principales: Atayık, Emel, Aytekin, Gökhan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Turkish Thoracic Society 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524494/
https://www.ncbi.nlm.nih.gov/pubmed/35957566
http://dx.doi.org/10.5152/TurkThoracJ.2022.22023

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9524494/
https://www.ncbi.nlm.nih.gov/pubmed/35957566
http://dx.doi.org/10.5152/TurkThoracJ.2022.22023

Ejemplares similares